How mild cognitive impairment treatment can Save You Time, Stress, and Money.
Because individuals that carry the APOE e4 gene variant show up to have a increased chance of significant problems, the FDA suggests remaining tested with the gene variant before beginning treatment with lecanemab or donanemab.Also, persons taking lecanemab or donanemab can have swelling in the brain or may possibly get compact bleeds in the brain.